ztalmy
marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - andre antiepileptika - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.
tegretal retard 400 mg depottabletter
europharma.dk aps - carbamazepin - depottabletter - 400 mg
tegretol cr 400 mg depottabletter
orifarm a/s - carbamazepin - depottabletter - 400 mg
alfaxan 10 mg/ml injektionsvæske, opløsning
jurox (ireland) limited - alfaxalonum - injektionsvæske, opløsning - 10 mg/ml